Cholesterol-binding motifs in STING that control endoplasmic reticulum retention mediate anti-tumoral activity of cholesterol-lowering compounds

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: Cholesterol-binding motifs in STING that control endoplasmic reticulum retention mediate anti-tumoral activity of cholesterol-lowering compounds ; volume:15 ; number:1 ; day:29 ; month:3 ; year:2024 ; pages:1-17 ; date:12.2024
Nature Communications ; 15, Heft 1 (29.3.2024), 1-17, 12.2024

Creator: Zhang, Bao-cun
Laursen, Marlene F.
Hu, Lili
Hazrati, Hossein
Narita, Ryo
Jensen, Lea S.
Hansen, Aida S.
Huang, Jinrong
Zhang, Yan
Ding, Xiangning
Muyesier, Maimaitili
Nilsson, Emil
Banasik, Agnieszka
Zeiler, Christina
Mogensen, Trine H.
Etzerodt, Anders
Agger, Ralf
Johannsen, Mogens
Kofod-Olsen, Emil
Paludan, Søren R.
Jakobsen, Martin R.

Contributor: SpringerLink (Online service)

DOI: 10.1038/s41467-024-47046-5

URN: urn:nbn:de:101:1-2406170949018.878569457965

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:55 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Zhang, Bao-cun
Laursen, Marlene F.
Hu, Lili
Hazrati, Hossein
Narita, Ryo
Jensen, Lea S.
Hansen, Aida S.
Huang, Jinrong
Zhang, Yan
Ding, Xiangning
Muyesier, Maimaitili
Nilsson, Emil
Banasik, Agnieszka
Zeiler, Christina
Mogensen, Trine H.
Etzerodt, Anders
Agger, Ralf
Johannsen, Mogens
Kofod-Olsen, Emil
Paludan, Søren R.
Jakobsen, Martin R.
SpringerLink (Online service)

Other Objects (12)

Cholesterol-Lowering Super juice

Cholesterol lowering: role in cancer prevention and treatment

Low-density lipoprotein cholesterol lowering treatment: the current approach

Short-term LDL cholesterol-lowering efficacy of plant stanol esters

Cholesterol transfer via endoplasmic reticulum contacts mediates lysosome damage repair

PCSK9 inhibition: the dawn of a new age in cholesterol lowering?

Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammation

Cholesterol-Lowering Therapy in Patients at Low-to-Moderate Cardiovascular Risk

Lowering blood cholesterol does not affect neuroinflammation in experimental autoimmune encephalomyelitis

Cholesterol metabolism—physiological regulation and pathophysiological deregulation by the endoplasmic reticulum

Eligibility for PCSK9 treatment in 734 Hypercholesterolemic patients referred to a regional cholesterol treatment center with LDL cholesterol ≥70 mg/dl despite maximal tolerated cholesterol lowering therapy

PERK‐Mediated Cholesterol Excretion from IDH Mutant Glioma Determines Anti‐Tumoral Polarization of Microglia

Cholesterol-Lowering Super juice

Cholesterol lowering: role in cancer prevention and treatment

Low-density lipoprotein cholesterol lowering treatment: the current approach

Short-term LDL cholesterol-lowering efficacy of plant stanol esters

Cholesterol transfer via endoplasmic reticulum contacts mediates lysosome damage repair

PCSK9 inhibition: the dawn of a new age in cholesterol lowering?

Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammation

Cholesterol-Lowering Therapy in Patients at Low-to-Moderate Cardiovascular Risk

Lowering blood cholesterol does not affect neuroinflammation in experimental autoimmune encephalomyelitis

Cholesterol metabolism—physiological regulation and pathophysiological deregulation by the endoplasmic reticulum

Eligibility for PCSK9 treatment in 734 Hypercholesterolemic patients referred to a regional cholesterol treatment center with LDL cholesterol ≥70 mg/dl despite maximal tolerated cholesterol lowering therapy

PERK‐Mediated Cholesterol Excretion from IDH Mutant Glioma Determines Anti‐Tumoral Polarization of Microglia

Cholesterol-Lowering Super juice

Cholesterol lowering: role in cancer prevention and treatment

Low-density lipoprotein cholesterol lowering treatment: the current approach

Short-term LDL cholesterol-lowering efficacy of plant stanol esters

Cholesterol transfer via endoplasmic reticulum contacts mediates lysosome damage repair

PCSK9 inhibition: the dawn of a new age in cholesterol lowering?

Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammation

Cholesterol-Lowering Therapy in Patients at Low-to-Moderate Cardiovascular Risk

Lowering blood cholesterol does not affect neuroinflammation in experimental autoimmune encephalomyelitis

Cholesterol metabolism—physiological regulation and pathophysiological deregulation by the endoplasmic reticulum

Eligibility for PCSK9 treatment in 734 Hypercholesterolemic patients referred to a regional cholesterol treatment center with LDL cholesterol ≥70 mg/dl despite maximal tolerated cholesterol lowering therapy

PERK‐Mediated Cholesterol Excretion from IDH Mutant Glioma Determines Anti‐Tumoral Polarization of Microglia

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Cholesterol-binding motifs in STING that control endoplasmic reticulum retention mediate anti-tumoral activity of cholesterol-lowering compounds

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Cholesterol-Lowering Super juice

Cholesterol lowering: role in cancer prevention and treatment

Low-density lipoprotein cholesterol lowering treatment: the current approach

Short-term LDL cholesterol-lowering efficacy of plant stanol esters

Cholesterol transfer via endoplasmic reticulum contacts mediates lysosome damage repair

PCSK9 inhibition: the dawn of a new age in cholesterol lowering?

Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammation

Cholesterol-Lowering Therapy in Patients at Low-to-Moderate Cardiovascular Risk

Lowering blood cholesterol does not affect neuroinflammation in experimental autoimmune encephalomyelitis

Cholesterol metabolism—physiological regulation and pathophysiological deregulation by the endoplasmic reticulum

Eligibility for PCSK9 treatment in 734 Hypercholesterolemic patients referred to a regional cholesterol treatment center with LDL cholesterol ≥70 mg/dl despite maximal tolerated cholesterol lowering therapy

PERK‐Mediated Cholesterol Excretion from IDH Mutant Glioma Determines Anti‐Tumoral Polarization of Microglia

Cholesterol-Lowering Super juice

Cholesterol lowering: role in cancer prevention and treatment

Low-density lipoprotein cholesterol lowering treatment: the current approach

Short-term LDL cholesterol-lowering efficacy of plant stanol esters

Cholesterol transfer via endoplasmic reticulum contacts mediates lysosome damage repair

PCSK9 inhibition: the dawn of a new age in cholesterol lowering?

Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammation

Cholesterol-Lowering Therapy in Patients at Low-to-Moderate Cardiovascular Risk

Lowering blood cholesterol does not affect neuroinflammation in experimental autoimmune encephalomyelitis

Cholesterol metabolism—physiological regulation and pathophysiological deregulation by the endoplasmic reticulum

Eligibility for PCSK9 treatment in 734 Hypercholesterolemic patients referred to a regional cholesterol treatment center with LDL cholesterol ≥70 mg/dl despite maximal tolerated cholesterol lowering therapy

PERK‐Mediated Cholesterol Excretion from IDH Mutant Glioma Determines Anti‐Tumoral Polarization of Microglia

Cholesterol-Lowering Super juice

Cholesterol lowering: role in cancer prevention and treatment

Low-density lipoprotein cholesterol lowering treatment: the current approach

Short-term LDL cholesterol-lowering efficacy of plant stanol esters

Cholesterol transfer via endoplasmic reticulum contacts mediates lysosome damage repair

PCSK9 inhibition: the dawn of a new age in cholesterol lowering?

Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammation

Cholesterol-Lowering Therapy in Patients at Low-to-Moderate Cardiovascular Risk

Lowering blood cholesterol does not affect neuroinflammation in experimental autoimmune encephalomyelitis

Cholesterol metabolism—physiological regulation and pathophysiological deregulation by the endoplasmic reticulum

Eligibility for PCSK9 treatment in 734 Hypercholesterolemic patients referred to a regional cholesterol treatment center with LDL cholesterol ≥70 mg/dl despite maximal tolerated cholesterol lowering therapy

PERK‐Mediated Cholesterol Excretion from IDH Mutant Glioma Determines Anti‐Tumoral Polarization of Microglia

Related objects

Reset password